" Aromatase and the Pharmacogenomic Profile - Influence of CYP19A1 polymorphisms in the response of breast cancer patients treated with aromatase inhibitors".

Mestrado em Oncologia === Master Degree in Oncology

Bibliographic Details
Main Author:	Schmid, Heidi
Format:	Others
Language:	Portuguese
Published:	Instituto de Ciências Biomédicas Abel Salazar 2012
Subjects:	Porto
Online Access:	http://hdl.handle.net/10216/57191

Similar Items

Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
by: Junmei Cairns, et al.
Published: (2020-08-01)

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer
by: Karin Zins, et al.
Published: (2014-01-01)

(TTTA)n polymorphism of CYP19 (aromatase gene) in Euro- and Afro-Brazilians
by: Kátia Kvitko, et al.
Published: (2004-01-01)

Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
by: Ekaterina Nevedomskaya, et al.
Published: (2014-12-01)

The Association between Aromatase Gene Polymorphism Cyp19 Val 80 and Endometriosis Risk
by: Syifa Alkaf, et al.
Published: (2021-01-01)

A Polymorphism at the 3'-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
by: Qing-Yuan Zhang, et al.
Published: (2013-09-01)

Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor
by: Somsri Wiwanitkit, et al.
Published: (2013-06-01)

Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009-07-01)

Clinical utilities of aromatase inhibitors in breast cancer
by: Chumsri S
Published: (2015-05-01)

Transcriptional signatures as early predictors of response in breast cancers treated with neoadjuvant aromatase inhibitors
by: Murray, Emma L.
Published: (2014)

Network-guided prediction of aromatase inhibitor response in breast cancer.
by: Matthew Ruffalo, et al.
Published: (2019-02-01)

Inibidores da aromatase e cancro da mama: Avaliação biológica de novas moléculas esteroides
by: Dias, Ana Margarida de Azevedo
Published: (2010)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
by: Swaathi Jayaraman, et al.
Published: (2020-05-01)

Expression Pattern and Enzymatic Study of Zebrafish cyp19 gene (Aromatase)
by: Tong, Sok-Keng, et al.
Published: (1999)

The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue
by: D. V. Lytkin, et al.
Published: (2018-08-01)

Aromatase inhibitors in the treatment of endometriosis
by: Radosław Słopień, et al.
Published: (2016-03-01)

Molecular Docking of Aromatase Inhibitors
by: Virapong Prachayasittikul, et al.
Published: (2011-04-01)

Aromatase inhibitors in male sex
by: Santosh Kumar Singh
Published: (2013-01-01)

Natural Inhibitors of the Aromatase Enzyme
by: Roberto R. Gil
Published: (2000-03-01)

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Maria Duarte da Silva Cepa
Published: (2019)

A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer
by: Abhinav Iyengar, et al.
Published: (2013-01-01)

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Cepa, et al.
Published: (2015-10-01)

Association Study of Aromatase Gene (CYP19A1) in Essential Hypertension
by: Masanori Shimodaira, Tomohiro Nakayama, Naoyuki Sato, Kosuke Saito, Akihiko Morita, Ichiro Sato, Teruyuki Takahashi, Masayoshi Soma, Yoichi Izumi
Published: (2008-01-01)

Testis morphology in rats chronically treated with letrozole, an aromatase inhibitor
by: Lidia Wenda-Różewicka, et al.
Published: (2012-01-01)

Simple tandem repeat (TTTA)<sub>n </sub>polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women
by: Okobia Michael N, et al.
Published: (2006-05-01)

Aromatase inhibitors in the treatment of deep endometriosis
by: Simone Ferrero, et al.
Published: (2009-09-01)

Aromatase inhibitors in stimulated IVF cycles
by: Tournaye Herman, et al.
Published: (2011-06-01)

Aromatase inhibitors in post-menopausal endometriosis
by: Devroey Paul, et al.
Published: (2011-06-01)

Synthesis and evaluation of potential aromatase inhibitors
by: Nazareth, W. M. A.
Published: (1988)

Synthetic methodology towards inhibitors of aromatase
by: Hares, Owen
Published: (1990)

Bone health history in breast cancer patients on aromatase inhibitors.
by: Marilyn L Kwan, et al.
Published: (2014-01-01)

Long-term safety of aromatase inhibitors in the treatment of breast cancer
by: Jean-Marc A Nabholtz
Published: (2008-03-01)

Computational investigations of cytochrome P450 aromatase catalysis and biological evaluation of isoflavone aromatase inhibitors
by: Hackett, John C.
Published: (2004)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
by: Young Kyung Seo, et al.
Published: (2021-03-01)

Ekspresi Gen CYP19 Aromatase, Estrogen, Androgen pada penderita Periodontitis Agresif
by: Dahlia Herawati, et al.
Published: (2016-11-01)

AROMATASE AND NEUROREGENERATION
by: Zulvikar Syambani Ulhaq
Published: (2019-01-01)

From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors
by: Leonor Vasconcelos de Matos, et al.
Published: (2021-02-01)

Association of polymorphism of aromatase (CYP19A1) with the risk of complications in the application of hormonal contraception in women of reproductive age
by: E V Ivanova, et al.
Published: (2016-10-01)

Regulation of Ovarian Aromatase: Studies by Aromatase Assays in vitro and in vivo
by: Kirilovas, Dmitrijus
Published: (2003)